Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Detaylı Bibliyografya
Yazar:	Flora, Sanzida Alam
Diğer Yazarlar:	Azam, Faruque
Materyal Türü:	Tez
Dil:	English
Baskı/Yayın Bilgisi:	Brac University 2024
Konular:	NSCLC Tyrosine kinase inhibitor Efficacy endpoints Cancer therapy Lung cancer Lung cancer > Treatment Protein-tyrosine kinase > Inhibitors > Therapeutic use
Online Erişim:	http://hdl.handle.net/10361/23693

Benzer Materyaller

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
Yazar:: Khan, Muidul Hasan
Baskı/Yayın Bilgisi: (2024)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Yazar:: Paul, Pulock
Baskı/Yayın Bilgisi: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
Yazar:: Rahman, Tasnim
Baskı/Yayın Bilgisi: (2024)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
Yazar:: Sorno, Rubina Haque
Baskı/Yayın Bilgisi: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
Yazar:: Hoque, Ismoth Ara
Baskı/Yayın Bilgisi: (2024)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Yazar:: Karim, Samia Binte
Baskı/Yayın Bilgisi: (2024)

Immunotherapy in the Management of Lung Cancer
Yazar:: Tasnim, Humayra
Baskı/Yayın Bilgisi: (2022)

Molecules associated with the development of lung cancer
Yazar:: Rahman, Adree, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Protein biomarkers for Lung Cancer: a bioinformatic approach
Yazar:: Jeba, Joynob
Baskı/Yayın Bilgisi: (2017)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
Yazar:: Meem, Manila
Baskı/Yayın Bilgisi: (2023)

A review on targeted therapies for lung cancer
Yazar:: Ashraf, Anushey
Baskı/Yayın Bilgisi: (2023)

Potential of liposomes for the treatment of lung cancer- a review
Yazar:: Mim, Shanzida
Baskı/Yayın Bilgisi: (2023)

A review on recent advances in drugs for lung cancer treatment
Yazar:: Noor, Fouzia
Baskı/Yayın Bilgisi: (2024)

A review on potential of PARP inhibitors in the treatment of prostate cancer
Yazar:: Islam, Saidul
Baskı/Yayın Bilgisi: (2022)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
Yazar:: Das, Reshita
Baskı/Yayın Bilgisi: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
Yazar:: Pial, Sazia Afrin
Baskı/Yayın Bilgisi: (2018)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
Yazar:: Razna, Amrin Islam
Baskı/Yayın Bilgisi: (2019)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
Yazar:: Shobnam, Sohana
Baskı/Yayın Bilgisi: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
Yazar:: Shabnam, Musharrat
Baskı/Yayın Bilgisi: (2018)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
Yazar:: Zangmo, Thinley
Baskı/Yayın Bilgisi: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Yazar:: Tania, Umme
Baskı/Yayın Bilgisi: (2023)

In silico modelling and structural dynamics of PSY1R kinase domain and its interaction with SERK1 kinase
Yazar:: Ruhee, Noshin Nawer
Baskı/Yayın Bilgisi: (2022)

RIPK pathway, as a potential target, for cancer treatment - a review
Yazar:: Jahan, Nusrat
Baskı/Yayın Bilgisi: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
Yazar:: Bristy, Israt Zerin
Baskı/Yayın Bilgisi: (2021)

Lung cancer detection and classification using machine learning
Yazar:: Arefin, Mahbubul, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
Yazar:: Karim, Azrin
Baskı/Yayın Bilgisi: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
Yazar:: Haque, Mushfiqul
Baskı/Yayın Bilgisi: (2019)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
Yazar:: Mukti, Roushney Fatima, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

A review on insulin-producing beta cell: regenerative role of drugs acting on DYRK1A, GLP-1 and DPP-4 receptors
Yazar:: Mahmood, Nyrit
Baskı/Yayın Bilgisi: (2021)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
Yazar:: Ratu, Tabassum
Baskı/Yayın Bilgisi: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
Yazar:: Mirza, Maisa Tasnim
Baskı/Yayın Bilgisi: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
Yazar:: Nandy, Aditi
Baskı/Yayın Bilgisi: (2022)

Statistics and informatics in molecular cancer research

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
Yazar:: Hasan, Amit
Baskı/Yayın Bilgisi: (2024)

Identification of FAP inhibitors using in silico simulation study
Yazar:: Deeba, Maliha Tasnim
Baskı/Yayın Bilgisi: (2018)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
Yazar:: Abir, Shifaty Nur
Baskı/Yayın Bilgisi: (2024)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
Yazar:: Hossain, Safa Binte
Baskı/Yayın Bilgisi: (2019)

Recent advances in Cancer treatment targeting autophagy and future aspects
Yazar:: Emon, Kamrul Hasan
Baskı/Yayın Bilgisi: (2022)

Cancer risk factors: a critical review
Yazar:: Tabassum, Tahsina
Baskı/Yayın Bilgisi: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
Yazar:: Nawar, Anika
Baskı/Yayın Bilgisi: (2019)